
Synexa Life Sciences expands operations in North America with new Rockville laboratory site
World Leaders in Biomarker and Bioanalysis Research Services
We are deeply saddened to share the news with you that our friend, colleague, mentor and Chief Scientific Officer, Matti Kimberg, unexpectedly passed away on 10 July 2022. Matti was not only a truly extraordinary scientist but more importantly also a remarkable person whose gentle nature, enthusiasm and sincere concern for people left an indelible mark on all that he met. Matti was instrumental in helping to weave the fabric of Synexa’s ethos and identity and he will be greatly missed.
Our hearts go out to Matti’s family and loved ones for whom this is as much a shock as it is to his Synexa Family. Your patience and support will be greatly appreciated over this period. Dr. Justin Devine (Synexa’s CMO) will in the interim take on the role of Chief Scientific Officer.

Biomarker & Bioanalytical expertise
Synexa Life Sciences has been providing expert insights for the clinical development of therapeutics for almost 20 years.
Insights that will improve the quality of decision-making through each stage of a therapeutic’s development.
Invaluable insight into the bioanalytical profile of large molecule therapeutics.
Our human in vitro translational ProtoTrials® platform provides unique and translatable insights into a therapeutic’s potential, safety and efficacy.
Services &
Capabilities
- Cell and gene therapy bioanalysis
- Large and novel molecule bioanalysis
- Vaccines
- Biosimilars
- Functional and translational assays
- Biomarker discovery, detection and interpretation
Bridging the gap between science and life.
Discuss real solutions to develop your therapeutic pipeline.
Join our next live webinar
Join us as we discuss overcoming challenges to COVID-19 clinical trials, on Tues 27 Jul 2021.
News and
articles
- August 3, 2022
A Quick Guide to Biomarker Solutions
- April 22, 2022
Fibrosis and SMAD signalling
- March 24, 2022
Lipids as Biomarkers of Brain Disorders
- May 20, 2021
Behind the wave
- January 20, 2021
Immunogenicity 101: Antidrug Antibodies, Neutralizing Antibodies, and everything in between
- October 2, 2020